Contact the CALQUENCE (acalabrutinib) team


If you have any questions or would like to speak to an AstraZeneca representative, please complete the form below.

Note: Your personal details will not be used for any promotional purposes unless you choose to opt in to promotional content by
checking the box below. More details can be found in our Privacy Policy.

 


Meet the team

Andy Simpson
National Sales Manager

Steph Psaroudakis
East Anglia

Kirstin Eden
North East England

Paula Marshall
North West England and North Wales

Amy Cull
South West England and South Wales

Angela Chahal
Midlands

Michael Donald
Scotland and Northern Ireland

Alex Thomas
London

Scarlett Goddard
South East and South
Central England

Adverse events should be reported

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting contactazmedical.astrazeneca.com or by calling 0800 783 0033.

May 2025 I GB-62240